Walmart Halts Sales Of Zantac Amid Growing Health Concerns

Erica Brosnan
October 02, 2019 - 7:33 pm

NEW YORK (WCBS 880) — Walmart on Wednesday became the latest store to pull Zantac, a popular heartburn treatment, from its shelves amid growing concern over a potentially dangerous contaminant in the drug.

The nation’s largest retailer announced it would no longer sell the heartburn medication and would no longer sell any drug that includes Zantac’s active ingredient, ranitidine.

The U.S. Food and Drug Administration announced last month that low level of a possibly cancer-causing chemical was detected in Zantac and its alternative generics.

The same chemical has been linked to dozens of recalls of prescription blood pressure drugs over the past year.

Already, CVS, Walgreens and Rite Aid have also pulled the product from shelves.